Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antipsychotic Boxed Warning Will Caution Against Off-Label Use In Dementia

Executive Summary

FDA is asking manufacturers of atypical antipsychotics to add a "black box" warning to labeling on an increased mortality risk associated with the drugs' off-label use to treat dementia-related behavioral disorders

You may also be interested in...



Boxed Warning For Antipsychotics First Public Use Of FDA Labeling Authority

FDA put its new labeling authority under the FDA Amendments Act on public display June 16 by directing makers of conventional antipsychotics to add to their drugs' prescribing information a boxed warning about use in elderly patients with dementia

Boxed Warning For Antipsychotics First Public Use Of FDA Labeling Authority

FDA put its new labeling authority under the FDA Amendments Act on public display June 16 by directing makers of conventional antipsychotics to add to their drugs' prescribing information a boxed warning about use in elderly patients with dementia

Antipsychotics Commonly Used Off-Label By Dementia Patients, AHRQ Finds

About 25 percent of people with dementia living in either a community setting or long-term care facility receive cholinesterase inhibitors, a government-funded study found

Related Content

Topics

UsernamePublicRestriction

Register

PS045659

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel